Abstract
Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have